Announcement on HS387 Tablets Obtaining the U.S. FDA Approval for Clinical Trials of a New Drug

About this update from Zhejiang Hisun Pharmaceutical Co., Ltd. Class A

Announcement on HS387 Tablets Obtaining the U.S. FDA Approval for Clinical Trials of a New Drug The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Zhejiang Hisun Pharmaceutical Co., Ltd. Class A